/term/net-income-including-noncontrolling-interests/SZSE:300233 Shandong Jincheng Pharmaceutical Group Co (SZSE:300233) Net
GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Shandong Jincheng Pharmaceutical Group Co Ltd (SZSE:300233) » Definitions » Net Income Including Noncontrolling Interests

Shandong Jincheng Pharmaceutical Group Co (SZSE:300233) Net Income Including Noncontrolling Interests : ¥228 Mil (TTM As of Mar. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Shandong Jincheng Pharmaceutical Group Co Net Income Including Noncontrolling Interests?

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Shandong Jincheng Pharmaceutical Group Co's Net Income Including Noncontrolling Interests for the three months ended in Mar. 2024 was ¥89 Mil. Its Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Mar. 2024 was ¥228 Mil.


Shandong Jincheng Pharmaceutical Group Co Net Income Including Noncontrolling Interests Historical Data

The historical data trend for Shandong Jincheng Pharmaceutical Group Co's Net Income Including Noncontrolling Interests can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandong Jincheng Pharmaceutical Group Co Net Income Including Noncontrolling Interests Chart

Shandong Jincheng Pharmaceutical Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Income Including Noncontrolling Interests
Get a 7-Day Free Trial Premium Member Only Premium Member Only 214.01 -480.68 123.08 285.88 193.31

Shandong Jincheng Pharmaceutical Group Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Net Income Including Noncontrolling Interests Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 54.88 55.89 35.88 46.66 89.16

Shandong Jincheng Pharmaceutical Group Co Net Income Including Noncontrolling Interests Calculation

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥228 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shandong Jincheng Pharmaceutical Group Co Net Income Including Noncontrolling Interests Related Terms

Thank you for viewing the detailed overview of Shandong Jincheng Pharmaceutical Group Co's Net Income Including Noncontrolling Interests provided by GuruFocus.com. Please click on the following links to see related term pages.


Shandong Jincheng Pharmaceutical Group Co (SZSE:300233) Business Description

Traded in Other Exchanges
N/A
Address
No. 1 Shuangshan Road, Zichuan Economic Development Zone, Shandong, Zibo, CHN, 255100
Shandong Jincheng Pharmaceutical Group Co Ltd is engaged in the research and development, production and sale of III and IV cephalosporin intermediates and biopharmaceuticals. It offers characteristic bulk drugs, pharmaceutical intermediates, and fine chemicals. The company distributes its products within domestic market and to overseas markets.
Executives
Yang Xiu Liang Executives
Zhang Xue Bo Director
Zheng Geng Xiu Director
Zhao Ye Qing Director
Sun Rui Mei Executives
Cui Xi Li Executives
Zhao Hong Fu Director
Fu Miao Qing Executives
Zhu Xiao Gang Directors, executives
Li Jia Quan Directors, executives
Guo Fang Shui Supervisors
Chou Qiang Securities Affairs Representative

Shandong Jincheng Pharmaceutical Group Co (SZSE:300233) Headlines

No Headlines